Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Pillars Article: Characterization of a Monoclonal Antibody Which Detects All Murine αβ T Cell Receptors. J. Immunol. 1989. 142: 2736-2742.

Kubo RT, Born W, Kappler JW, Marrack P, Pigeon M.

J Immunol. 2016 Nov 1;197(9):3437-3443. No abstract available.

2.

Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5.

Benhnia MR, McCausland MM, Laudenslager J, Granger SW, Rickert S, Koriazova L, Tahara T, Kubo RT, Kato S, Crotty S.

J Virol. 2009 Dec;83(23):12355-67. doi: 10.1128/JVI.01593-09. Epub 2009 Sep 30.

3.

Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein.

Wang R, Song A, Levin J, Dennis D, Zhang NJ, Yoshida H, Koriazova L, Madura L, Shapiro L, Matsumoto A, Yoshida H, Mikayama T, Kubo RT, Sarawar S, Cheroutre H, Kato S.

Antiviral Res. 2008 Nov;80(2):168-77. doi: 10.1016/j.antiviral.2008.06.002. Epub 2008 Jul 1.

PMID:
18598723
4.

Lipopeptide particles as the immunologically active component of CTL inducing vaccines.

Tsunoda I, Sette A, Fujinami RS, Oseroff C, Ruppert J, Dahlberg C, Southwood S, Arrhenius T, Kuang LQ, Kubo RT, Chesnut RW, Ishioka GY.

Vaccine. 1999 Feb 26;17(7-8):675-85.

PMID:
10067673
5.

Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses.

Oseroff C, Sette A, Wentworth P, Celis E, Maewal A, Dahlberg C, Fikes J, Kubo RT, Chesnut RW, Grey HM, Alexander J.

Vaccine. 1998 May;16(8):823-33.

PMID:
9627940
6.

Several common HLA-DR types share largely overlapping peptide binding repertoires.

Southwood S, Sidney J, Kondo A, del Guercio MF, Appella E, Hoffman S, Kubo RT, Chesnut RW, Grey HM, Sette A.

J Immunol. 1998 Apr 1;160(7):3363-73.

7.

Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes.

Alexander J, Oseroff C, Sidney J, Wentworth P, Keogh E, Hermanson G, Chisari FV, Kubo RT, Grey HM, Sette A.

J Immunol. 1997 Nov 15;159(10):4753-61. Erratum in: J Immunol 1999 Mar 1;162(5):3104.

PMID:
9366399
8.

Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo.

del Guercio MF, Alexander J, Kubo RT, Arrhenius T, Maewal A, Appella E, Hoffman SL, Jones T, Valmori D, Sakaguchi K, Grey HM, Sette A.

Vaccine. 1997 Mar;15(4):441-8.

PMID:
9141216
9.

Two distinct HLA-A*0101-specific submotifs illustrate alternative peptide binding modes.

Kondo A, Sidney J, Southwood S, del Guercio MF, Appella E, Sakamoto H, Grey HM, Celis E, Chesnut RW, Kubo RT, Sette A.

Immunogenetics. 1997;45(4):249-58.

PMID:
9002445
10.

Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules.

Sidney J, Southwood S, del Guercio MF, Grey HM, Chesnut RW, Kubo RT, Sette A.

J Immunol. 1996 Oct 15;157(8):3480-90.

PMID:
8871647
11.

Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs.

Sidney J, Grey HM, Kubo RT, Sette A.

Immunol Today. 1996 Jun;17(6):261-6. Review. No abstract available.

PMID:
8962628
12.

Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules.

Sidney J, Grey HM, Southwood S, Celis E, Wentworth PA, del Guercio MF, Kubo RT, Chesnut RW, Sette A.

Hum Immunol. 1996 Feb;45(2):79-93.

PMID:
8882405
13.

Physical dissociation of the TCR-CD3 complex accompanies receptor ligation.

Kishimoto H, Kubo RT, Yorifuji H, Nakayama T, Asano Y, Tada T.

J Exp Med. 1995 Dec 1;182(6):1997-2006.

14.

Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules.

Kondo A, Sidney J, Southwood S, del Guercio MF, Appella E, Sakamoto H, Celis E, Grey HM, Chesnut RW, Kubo RT, Sette A.

J Immunol. 1995 Nov 1;155(9):4307-12.

PMID:
7594589
15.

In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides.

Wentworth PA, Celis E, Crimi C, Stitely S, Hale L, Tsai V, Serra HM, Del Guercio MF, Livingston B, Alazard D, Fikes J, Kubo RT, Grey HM, Chesnut RW, Chisari FV, Sette A.

Mol Immunol. 1995 Jun;32(9):603-12.

PMID:
7643853
16.

Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype.

del Guercio MF, Sidney J, Hermanson G, Perez C, Grey HM, Kubo RT, Sette A.

J Immunol. 1995 Jan 15;154(2):685-93.

PMID:
7529283
17.

Analysis of MHC-specific peptide motifs. Applications in immunotherapy.

Loftus DJ, Kubo RT, Sakaguchi K, Celis E, Sette A, Appella E.

Adv Exp Med Biol. 1995;383:201-10. Review.

PMID:
8644503
18.

Design and testing of peptide-based cytotoxic T-cell-mediated immunotherapeutics to treat infectious diseases and cancer.

Chesnut RW, Sette A, Celis E, Wentworth P, Kubo RT, Alexander J, Ishioka G, Vitiello A, Grey HM.

Pharm Biotechnol. 1995;6:847-74. Review. No abstract available.

PMID:
7551252
19.

Class I MHC-peptide interactions: structural requirements and functional implications.

Grey HM, Ruppert J, Vitiello A, Sidney J, Kast WM, Kubo RT, Sette A.

Cancer Surv. 1995;22:37-49. Review.

PMID:
7536628
20.

Several HLA alleles share overlapping peptide specificities.

Sidney J, del Guercio MF, Southwood S, Engelhard VH, Appella E, Rammensee HG, Falk K, Rötzschke O, Takiguchi M, Kubo RT, et al.

J Immunol. 1995 Jan 1;154(1):247-59.

PMID:
7527812
21.

The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.

Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, Melief CJ, Oseroff C, Yuan L, Ruppert J, Sidney J, del Guercio MF, Southwood S, Kubo RT, Chesnut RW, Grey HM, Chisari FV.

J Immunol. 1994 Dec 15;153(12):5586-92.

PMID:
7527444
22.

Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.

Alexander J, Sidney J, Southwood S, Ruppert J, Oseroff C, Maewal A, Snoke K, Serra HM, Kubo RT, Sette A, et al.

Immunity. 1994 Dec;1(9):751-61.

PMID:
7895164
24.

Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays.

Sette A, Sidney J, del Guercio MF, Southwood S, Ruppert J, Dahlberg C, Grey HM, Kubo RT.

Mol Immunol. 1994 Aug;31(11):813-22.

PMID:
8047072
25.

Class I MHC-peptide interaction: structural and functional aspects.

Ruppert J, Kubo RT, Sidney J, Grey HM, Sette A.

Behring Inst Mitt. 1994 Jul;(94):48-60. Review.

PMID:
7998914
26.

Definition of specific peptide motifs for four major HLA-A alleles.

Kubo RT, Sette A, Grey HM, Appella E, Sakaguchi K, Zhu NZ, Arnott D, Sherman N, Shabanowitz J, Michel H, et al.

J Immunol. 1994 Apr 15;152(8):3913-24.

PMID:
8144960
27.

Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.

Kast WM, Brandt RM, Sidney J, Drijfhout JW, Kubo RT, Grey HM, Melief CJ, Sette A.

J Immunol. 1994 Apr 15;152(8):3904-12.

PMID:
7511661
28.

Inhibition of allograft rejection by anti-T-cell receptor-alpha beta monoclonal antibodies preserving resistance to bacterial infection.

Eto M, Yoshikai Y, Nishimura Y, Hiromatsu K, Maeda T, Nomoto K, Kong YY, Kubo RT, Kumazawa J, Nomoto K.

Immunology. 1994 Feb;81(2):198-204.

29.

Expression and function of mixed isotype MHC class II molecules in normal mice.

Spencer JS, Freed JH, Kubo RT.

J Immunol. 1993 Dec 15;151(12):6822-32.

PMID:
8258692
30.

Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules.

Ruppert J, Sidney J, Celis E, Kubo RT, Grey HM, Sette A.

Cell. 1993 Sep 10;74(5):929-37.

PMID:
8104103
31.

Isolation and characterization of naturally processed peptides bound by class II molecules and peptides presented by normal and mutant antigen-presenting cells.

Sette A, DeMars R, Grey HM, Oseroff C, Southwood S, Appella E, Kubo RT, Hunt DF.

Chem Immunol. 1993;57:152-65. No abstract available.

PMID:
8260087
32.

Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant.

Sette A, Ceman S, Kubo RT, Sakaguchi K, Appella E, Hunt DF, Davis TA, Michel H, Shabanowitz J, Rudersdorf R, et al.

Science. 1992 Dec 11;258(5089):1801-4.

PMID:
1465617
33.

Glycosylphosphatidyl inositol-linked membrane protein expression by intestinal intraepithelial lymphocytes.

de Geus B, HogenEsch H, Kubo RT, Rozing J.

Int Immunol. 1992 Aug;4(8):899-903.

PMID:
1358188
35.

Translocation of spectrin and protein kinase C to a cytoplasmic aggregate upon lymphocyte activation.

Gregorio CC, Kubo RT, Bankert RB, Repasky EA.

Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4947-51.

36.

Physical association of CD4 with the T cell receptor.

Dianzani U, Shaw A, al-Ramadi BK, Kubo RT, Janeway CA Jr.

J Immunol. 1992 Feb 1;148(3):678-88.

PMID:
1370513
37.

Surface expression of a T cell receptor beta (TCR-beta) chain in the absence of TCR-alpha, -delta, and -gamma proteins.

Punt JA, Kubo RT, Saito T, Finkel TH, Kathiresan S, Blank KJ, Hashimoto Y.

J Exp Med. 1991 Oct 1;174(4):775-83.

38.

In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes.

Shi YF, Bissonnette RP, Parfrey N, Szalay M, Kubo RT, Green DR.

J Immunol. 1991 May 15;146(10):3340-6.

PMID:
1827483
39.

Analysis of the interaction site for the self superantigen Mls-1a on T cell receptor V beta.

Pullen AM, Bill J, Kubo RT, Marrack P, Kappler JW.

J Exp Med. 1991 May 1;173(5):1183-92.

40.
41.

T-cell development and transmembrane signaling: changing biological responses through an unchanging receptor.

Finkel TH, Kubo RT, Cambier JC.

Immunol Today. 1991 Feb;12(2):79-85. Review.

PMID:
1829360
42.

Expression of functional alpha beta T cell receptor gene rearrangements in suppressor T cell hybridomas correlates with antigen binding, but not with suppressor cell function.

Collins M, Kuchroo VK, Whitters MJ, O'Hara RM Jr, Kelleher K, Kubo RT, Dorf ME.

J Immunol. 1990 Nov 1;145(9):2809-19.

PMID:
2170525
43.
45.

Antigen-specific and antibody-mediated growth inhibition of suppressor T cell hybridomas. Roles of H-2 and the CD3-T cell receptor-alpha/beta complex.

Kuchroo VK, Billings PR, Levine C, Martin CA, Kubo RT, Dorf ME.

J Immunol. 1990 Aug 15;145(4):1059-65.

PMID:
2143205
46.

Relationships between antigen-specific helper and inducer suppressor T cell hybridomas.

Kuchroo VK, Steele JK, O'Hara RM Jr, Jayaraman S, Selvaraj P, Greenfield E, Kubo RT, Dorf ME.

J Immunol. 1990 Jul 15;145(2):438-48.

PMID:
1973182
49.

Limited receptor repertoire in a mycobacteria-reactive subset of gamma delta T lymphocytes.

Happ MP, Kubo RT, Palmer E, Born WK, O'Brien RL.

Nature. 1989 Dec 7;342(6250):696-8.

PMID:
2594068
50.

The thymus has two functionally distinct populations of immature alpha beta + T cells: one population is deleted by ligation of alpha beta TCR.

Finkel TH, Cambier JC, Kubo RT, Born WK, Marrack P, Kappler JW.

Cell. 1989 Sep 22;58(6):1047-54.

PMID:
2673539

Supplemental Content

Support Center